Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): Implications for mechanism of action

2000-03-01

Additional Metadata
Persistent URL	doi.org/10.1128/AAC.44.3.732-738.2000, hdl.handle.net/1765/54256
Journal	Antimicrobial Agents and Chemotherapy
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Adrian, P., Zhao, W., Black, T., Shaw, K., Hare, R., & Klugman, K. (2000). Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): Implications for mechanism of action. Antimicrobial Agents and Chemotherapy, 44(3), 732–738. doi:10.1128/AAC.44.3.732-738.2000

Publication